Can AI smell you? This startup built a $130 million digital nose

Fortune
34 followers
44 Video Views·Jul 16, 2026
AI Generated·May contain errors
Our mission is to give computers a sense of smell.
For a century, we've been turning the world into data.
Sight became pixels.
Sound became waveforms.
But smell, the oldest sense no machine could digitize.
Until now.
For the first time ever, a teleported smell.
With a single prompt, this startup says they can create a scent in just 48 hours.
Completely reversing the model of how scent is designed and delivered.
We see a lot of textures in perfumery too.
But fragrance is just the beginning.
The final frontier is using scent in the way that dogs can use scent
to understand wellness or illness.
This AI startup has raised $130 million to turn scent into data.
Perfume now, disease detection down the line.
So what happens when you give a computer a nose?
We're going to smell the whole world.
For decades, four giants have dominated the $30 billion flavor and fragrance market.
Now Osmo's using AI to make it cheaper, faster, and more accessible.
Neuroscientist Alex Wilczko created Osmo with a mission.
Build the world's first olfactory intelligence.
AI trained to predict what a molecule will smell like.
What is Osmo?
Why did you create it?
What we're trying to do is bring new, unique scents to more people in the world.
By removing the gates in the secrecy and frankly some of the arrogance that like,
oh only certain companies or only certain people can have a good scent.
No, anybody can.
We're democratizing scent.
The idea of having Shazam for smell.
That you can walk into a room and just press a button
and it just digitally can find the frequency of the music
and match it to a correlated database.
You should have that same feeling when you walk into a room
and you smell a perfume or a cologne.
You're like, what is that?
Josh Wolfe is a venture capitalist
known for shaping cutting-edge tech into real businesses.
With a recently closed $1.5 billion fund,
Lux Capital now commands more than $7 billion in assets.
As one of the company's first outside investors,
the firm helped raise $60 million for Osmo's launch in 2023.
How do you distinguish between what is scientifically possible
and what is just hype?
It's really sophisticated, hard.
You need a PhD and it comes down to three words.
Does it work?
If you're looking at something that is a hypothesis
and you want to test it, then it's almost like a poker game.
And you want to ask how much capital accomplishes what,
in what period of time, and who will care?
The bet is paying off.
Osmo's signed clients from indie brands to multinational CPGs.
The company has authenticated sneakers by smell.
All you have to do is get the shoebox close to the sensor.
Reduced animal testing and received millions in funding
from the Gates Foundation to support AI-enabled insect control.
Altogether, raising $130 million in just four years.
How do you prove, though, that it's not just evocative,
but it's also really a business?
In our case, right now, you just smell the results.
I smell anxiety and 234 years of American capitalism.
We took Osmo's tech to the floor of the New York Stock Exchange
to see if a machine could actually capture the smell of ambition.
To bottle a place like this,
Osmo had to teach a machine to turn scent into numbers.
What does it actually mean to collect data for scent?
One is you have to make or acquire an actual physical smell.
And then you have to turn that physical smell into ones and zeros.
The breakthrough came from an unlikely place,
the AI built to discover new drugs.
They figured out how to teach AI to deal with inputs
that aren't shaped like a rectangle.
So images are rectangles.
They're grids of pixels.
Text is a very long, thin rectangle.
But molecules are atoms that click together
in all kinds of different shapes.
They're very much not a grid.
And so there was a set of techniques developed
to deal with that kind of input called graph neural networks.
In 2024, Osmo captured the smell of a real plum,
encoding it as data and rebuilding it across the lab.
No human involved.
We put that prompt of like,
give me the smell of the New York Stock Exchange
into Osmo Studio.
And Osmo Studio is able to take really anything
like text and image and convert it into scent.
What does the New York Stock Exchange smell like?
So the first one is woody, floral, earthy.
Well, it smells a lot better than New York Stock Exchange,
which is frankly a little bit of a sweatier place.
But it does actually smell like the digital quality of it.
Well, let me give you this direction
and see what you think of this.
That to me smells like the New York Stock Exchange.
Did we get it?
Yes, that to me smells like New York Stock Exchange.
This feels like a marble lobby where a musky warmth
settles on polished stone.
I can't stop smelling this.
At what point, if any,
was there a human touch in this process?
At the very beginning, when you and I actually designed this.
We're using a tool, we're using Osmo Studio
to create scent that like,
that's like using Canva or Photoshop or Figma.
Like we were the designers.
The brands behind most perfume, shampoo, and detergent
don't formulate their own scents.
They buy them from suppliers.
That's the enterprise business Osmo is disrupting.
The platform layer behind scent.
Now, to what extent is Osmo revenue generating?
What parts are in research?
For the first, I would say, two and a half years,
everything was R&D
because what we were staring at had so much scientific risk.
And after we teleported a scent,
we realized we've actually taken
a lot of that scientific risk off the table.
And so we're a hybrid.
We're highly technical,
but the fastest growing part of our company
is in manufacturing and in sales.
And we sell finished fragrance to emerging brands
that are growing super fast,
but we also sell the software capabilities
and access to our data for really large companies
that also trade in smell.
So we have a few different facets of our business,
but they all are involved in
making great fragrances for brands.
The big suppliers often take months
with many requiring bulk orders.
Osmo, on the other hand, serves smaller brands,
a market historically underserved.
You could have done this as a B2C business,
but you chose B2B specifically.
Why?
One thing I've noticed in B2C,
you can be successful as a brand
with an amazing story
and having amazing technology and science behind that can help,
but it might not be the single reason why you win.
And I wanted to set us up in a business
where we're kind of dragged into the future,
where we keep developing our technology,
keep developing our research
to achieve even greater ambitions
and getting better at the core science of scent
and unraveling the mystery of scent
to actually be good for the business.
Who are your competitors?
Who do you look at and say
they're also marching towards the same mountain?
I don't think there's anybody out there
that's as weird as we are.
I mean, there's companies that design
and manufacture scent for sure.
They've been around for hundreds of years.
We're doing it very differently, right?
So instead of it being a very gate kept process,
we actually show our formulas to people.
Traditionally, chemists test one molecule at a time.
Osmo, meanwhile, says they use AI
to screen billions at once,
selecting only the best candidates to develop.
The company says its success rates are 10 times higher
and that it's five times cheaper
compared to industry norms.
Osmo also says it published
more new fragrance ingredient patents
than the rest of the industry combined in 2025.
Where a traditional patent might cover one or two molecules,
Osmo's patents can include up to 250
and they hope that scale means more profitability.
What do you consider the moat for something like Osmo?
Some of it is the data
and then being able to be the only company
that can predictably produce something
with mathematical rigor every single time.
We want it just like somebody was tuning a guitar.
We want it to be a little bit more pungent
or a little bit spikier.
We want it to last for longer
and Alex can basically say,
okay, we're going to add this to this
and we're going to be able to do it
and we'll be able to do it every single time
reproducibly and predictably.
While AI expedites molecule discovery,
humans are the artists
who help craft them into a final scent.
So this, this is a mini experimental robot.
It can work day and night
and can do a lot of samples
because AI needs a lot of data.
It needs a lot of,
how do you make an apple?
How do you make fresh?
How do you make bone?
We have a lot of these, yes,
because they're very helpful.
Its name is Taylor Swift.
Ah, voila, that's it.
Yeah, every robot here has a name.
Christophe Lotomil,
one of the few master perfumers in the world,
leads Osmo's AI-human collaboration.
We know the AI is going to come
and people are working on it,
but what happens for us,
I think as a perfumer,
to get into AI
and now to steer it as well.
It's not all AI.
It's not all human.
It's this beautiful blend
of like creativity being unleashed
in new ways
that's enabled by the technology
that we've created.
But fragrance isn't the end game.
Osmo says it's building
towards something bigger,
a tool that could one day
help detect disease.
The final frontier
is using scent in the way
that dogs can use scent
to understand wellness or illness.
It's insanely hard.
Dogs have been trained,
who have sharper senses
of smell than we do,
to detect COVID, cancer,
Parkinson's, Alzheimer's.
And so every one of those diseases
has a signature.
For Osmo,
fragrance is the commercial work
paying for that longer-term research.
And the reason is like,
well, we have to fund ourselves,
right, in order to do that.
And the act of making fragrances
actually generates data
and understanding,
which is strengthening our platform
to make even more ambitious bets
in the future.
For Alex, that motivation is personal.
His father died of brain cancer,
a condition that some evidence suggests
has a unique scent.
What we need to uncover
is perhaps those are also
the same molecules
in someone who has brain cancer,
like my father had.
If you have a disease that's developing,
there's going to be something
that's going to change
about the scents
that are leaving your body.
And nobody knows
the details of what that is,
but we know that dogs can detect it.
And so what Osmo is,
is an organization,
a group of people
designed to unravel these mysteries,
kind of one by one,
in a way that is responsible
and resilient
and designed to last over time.
